NCT03348150 - Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

September 17, 2025

Study Completion Date

October 1, 2027

Conditions

Stomach NeoplasmPeritoneal Carcinomatosis

Interventions

PROCEDURE

Cytoreductive surgery + Gastrecomy

Complete cytoreduction followed by a (sub)total gastric resection with D2 lymphadenectomy.

DRUG

Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

HIPEC: perfusion with oxaliplatin (460mg/m2 ) (42 °C) followed by docetaxel (50mg/m2 ) (37°C)

Trial Locations (1)

Antoni van Leeuwenhoek/ Netherlands Cancer institute, Amsterdam